Stay updated on Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdds Cohen et al. 2026 article to Publications. Removes the 2025 online-ahead-of-print version of the same article.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter shows a new Revision: v3.4.2; the previous funding-status notice and an earlier Revision: v3.4.1 note were removed.SummaryDifference0.3%

- Check34 days agoChange DetectedAdded a site-wide notice informing users about a lapse in government funding and that the NIH Clinical Center is open, with status guidance. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedIntroduces a Show glossary control and updates metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the page revision now shown as v3.4.0. The prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' are removed.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now displays a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedThe study details page now includes expanded location listings across multiple US states and international regions (e.g., Alabama, California, Baden-Wurttemberg, Kanagawa, Tokyo). The revision tag has been updated to Revision: v3.3.3.SummaryDifference1%

Stay in the know with updates to Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.